Capt Rawlins, LTC Collen, and COL (Ret) Morris are all affiliated with the Pulmonary/Critical Care Service, Department of Medicine, San Antonio Military Medical Center, Fort Sam Houston, Texas.
References
Service members with asthma represent a unique and ever expanding patient population, given the role of potential respiratory exposures in SWA. Longitudinal follow-up is critical in conjunction with application of novel therapies as appropriate and understanding the impact of deployment-related respiratory exposures. These patients will continue to require care in the military health care system, the VA health care system, and in the private sector for decades to come.
Author disclosures Dr. Morris is a paid speaker for Spiriva by Boehringer-Ingelheim. The other authors have no financial interests to disclose. None of the authors have any relevant conflicts of interest to disclose. This study was not supported by any funding or financial sponsorship .
Disclaimer The opinions expressed herein are those of the author and do not necessarily reflect those of Federal Practitioner or Frontline Medical Communications Inc. This article may discuss unlabeled or investigational use of certain drugs. Please review complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.
The opinions in this manuscript do not constitute endorsement by San Antonio Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, Department of Defense, or the U.S. Government of the information contained therein. The authors alone are responsible for the content and writing of the paper.
